Well Referenced

Tag: drug safety

Drug-induced noninfectious myocarditis: a disproportionality analysis of the FAERS database

This 2025 study conducted a disproportionality analysis using the FDA Adverse Event Reporting System (FAERS) to identify drugs associated with noninfectious myocarditis. Analyzing data from 2004 to 2024, the researchers found 10,763 reports of noninfectious myocarditis. The top five drugs with the highest reporting odds ratios (RORs) were phendimetrazine tartrate

June 26, 2025 No Comments

RE: Pulmonary Hypertension Associated with Use of Phentermine?

This 2011 letter to the editor critiques a prior case report suggesting a link between phentermine monotherapy and pulmonary arterial hypertension (PAH). The authors argue that the case likely represents idiopathic PAH rather than being induced by phentermine. They reference epidemiological studies indicating no significant association between phentermine use and

June 26, 2025 No Comments

Appetite-suppressant drugs and the risk of primary pulmonary hypertension?

This 1997 editorial by M. Deitel discusses findings from a multicenter case-control study involving 95 patients with primary pulmonary hypertension (PPH) and 355 matched controls. The study identified a significant association between the use of anorexic agents, particularly fenfluramine derivatives, and the development of PPH. The risk increased with longer

June 26, 2025 No Comments